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（学位論文のタイトル） 
Distinct transduction profiles in the CNS via three injection routes of AAV9 and
 the application to generation of a neurodegenerative mouse model 
 （アデノ随伴ウイルスベクターの３つの投与経路の違いによる中枢神経系遺伝子発現の
差異、および神経変性疾患モデルマウス作成への応用） 




       Using single-stranded adeno-associated virus serotype 9 (ssAAV9)
 vectors containing the neuron-specific synapsin-I promoter, we examine
d whether different administration routes (direct cerebellar cortical 
(DC), intrathecal (IT) and intravenous (IV) injections) could elicit sp
ecific transduction profiles in the CNS. The DC injection route robustl
y and exclusively transduced the whole cerebellum, whereas the IT injec
tion route primarily transduced the cerebellar lobules 9 and 10 close t
o the injection site and the spinal cord. An IV injection in neonatal m
ice weakly and homogenously transduced broad CNS areas. In the cerebell
ar cortex, the DC and IT injection routes transduced all neuron types, 
whereas the IV injection route primarily transduced Purkinje cells. To 
verify the usefulness of this method, we generated a mouse model of spi
nocerebellar ataxia type 1 (SCA1). Mice that received a DC injection of
 the ssAAV9 vector expressing mutant ATXN1, a protein responsible for S
CA1, showed the intranuclear aggregation of mutant ATXN1 in Purkinje ce
lls, significant atrophy of the Purkinje cell dendrites and progressive
 motor deficits, which are characteristics of SCA1. Thus, ssAAV9-mediat
ed transduction areas, levels, and cell types change depending on the r
oute of injection. Moreover, this approach can be used for the generati
on of different mouse models of CNS/neurodegenerative diseases.  
 




















                                                                                
  
 
